ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,306.04
0.02%
Dow Jones
38,852.86
-0.55%
US Dollar vs MXN
16.7896
-0.04%
Brent Oil
84.165
-0.19%
Bitcoin
68,731.80
0.65%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Vital Therapies, Inc. (MM) (VTL)

  7. Vital Therapies, Inc. (MM) (VTL) Noticias

VTL

VITAL THERAPIES INC (VTL)

Vital Therapies, Inc. (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:VTL
FechaHoraFuenteTítuloSímboloCompañía
15/04/201915:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VTLVital Therapies, Inc. (MM)
12/04/201912:01PR Newswire (US)Immunic Therapeutics and Vital Therapies Complete Transaction Creating Nasdaq-Listed Company Targeting Chronic Inflammatory a...NASDAQ:VTLVital Therapies, Inc. (MM)
10/04/201915:35GlobeNewswire Inc.Vital Therapies, Inc. Announces Filing of its Form 10-Q for the Quarter Ended March 31, 2019NASDAQ:VTLVital Therapies, Inc. (MM)
10/04/201915:19Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VTLVital Therapies, Inc. (MM)
04/04/201915:07GlobeNewswire Inc.Vital Therapies, Inc. Announces Stockholder Approval of Business Combination with Immunic AGNASDAQ:VTLVital Therapies, Inc. (MM)
02/04/201915:20Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:VTLVital Therapies, Inc. (MM)
27/03/201915:08Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:VTLVital Therapies, Inc. (MM)
27/03/201905:00GlobeNewswire Inc.Vital Therapies Reminds Stockholders to Vote For the Proposed Business Combination With Immunic AGNASDAQ:VTLVital Therapies, Inc. (MM)
25/03/201904:00GlobeNewswire Inc.Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Vital Therapies Stockholders Vote “FOR” the Prop...NASDAQ:VTLVital Therapies, Inc. (MM)
04/03/201916:17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:VTLVital Therapies, Inc. (MM)
04/03/201915:10GlobeNewswire Inc.Vital Therapies Announces 2018 Financial ResultsNASDAQ:VTLVital Therapies, Inc. (MM)
19/02/201916:05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:VTLVital Therapies, Inc. (MM)
15/02/201905:33Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VTLVital Therapies, Inc. (MM)
14/02/201908:04Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:VTLVital Therapies, Inc. (MM)
04/02/201917:01Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:VTLVital Therapies, Inc. (MM)
01/02/201914:39Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VTLVital Therapies, Inc. (MM)
07/01/201903:00GlobeNewswire Inc.Vital Therapies and Immunic Therapeutics Announce Transaction to Create Leading Inflammatory and Autoimmune Disease CompanyNASDAQ:VTLVital Therapies, Inc. (MM)
07/11/201817:20GlobeNewswire Inc.Vital Therapies Announces Third Quarter 2018 Financial ResultsNASDAQ:VTLVital Therapies, Inc. (MM)
11/10/201808:27GlobeNewswire Inc.Vital Therapies Provides Strategic UpdateNASDAQ:VTLVital Therapies, Inc. (MM)
29/09/201809:00GlobeNewswire Inc.Vital Therapies to Present at the 19th International Liver Support MeetingNASDAQ:VTLVital Therapies, Inc. (MM)
25/09/201818:30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VTLVital Therapies, Inc. (MM)
18/09/201805:09Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:VTLVital Therapies, Inc. (MM)
12/09/201804:00GlobeNewswire Inc.Vital Therapies Announces That Topline Results of VTL-308 Fail to Achieve Primary and Secondary Endpoints of Improvement in S...NASDAQ:VTLVital Therapies, Inc. (MM)
07/08/201815:01GlobeNewswire Inc.Vital Therapies Announces Second Quarter 2018 Financial ResultsNASDAQ:VTLVital Therapies, Inc. (MM)
31/07/201815:01GlobeNewswire Inc.Vital Therapies Announces Upcoming Second Quarter Financial Results Conference Call With WebcastNASDAQ:VTLVital Therapies, Inc. (MM)
25/06/201807:00GlobeNewswire Inc.Vital Therapies Joins the Russell 3000 Index®NASDAQ:VTLVital Therapies, Inc. (MM)
12/06/201815:30GlobeNewswire Inc.Vital Therapies Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:VTLVital Therapies, Inc. (MM)
08/06/201806:56Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:VTLVital Therapies, Inc. (MM)
07/06/201807:00GlobeNewswire Inc.Vital Therapies to Present at the Jefferies 2018 Global Healthcare ConferenceNASDAQ:VTLVital Therapies, Inc. (MM)
25/05/201815:35Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:VTLVital Therapies, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:VTL

Su Consulta Reciente

NASDAQ
FUENCX
Interest Rate Hedge Port...
BIT
UB7X7L
Unicredit Bank
BIT
UB0P2J
UniCredit Bank
BIT
NSCIT0013325
Republic of France
BIT
CLE
Class Editori
BIT
UB891N
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados